Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in the hammerhead ribozyme field

N K Vaish1, A R Kore, F Eckstein

  • 1Max-Planck-Institut für experimentelle Medizin, Hermann-Rein-Strasse 3, D-37075 Göttingen, Germany.

Nucleic Acids Research
|November 25, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is local or central adiposity more strongly associated with incident knee osteoarthritis than the body mass index in men or women?

Osteoarthritis and cartilage·2018
Same author

Changes in the structural features of osteoarthritis in a year of weight loss.

Osteoarthritis and cartilage·2018
Same author

Predictive and concurrent validity of cartilage thickness change as a marker of knee osteoarthritis progression: data from the Osteoarthritis Initiative.

Osteoarthritis and cartilage·2017
Same author

Longitudinal change in thigh muscle strength prior to and concurrent with symptomatic and radiographic knee osteoarthritis progression: data from the Osteoarthritis Initiative.

Osteoarthritis and cartilage·2017
Same author

Subregional laminar cartilage MR spin-spin relaxation times (T2) in osteoarthritic knees with and without medial femorotibial cartilage loss - data from the Osteoarthritis Initiative (OAI).

Osteoarthritis and cartilage·2017
Same author

Between-group differences in infra-patellar fat pad size and signal in symptomatic and radiographic progression of knee osteoarthritis vs non-progressive controls and healthy knees - data from the FNIH Biomarkers Consortium Study and the Osteoarthritis Initiative.

Osteoarthritis and cartilage·2017

Recent advances in hammerhead ribozyme technology are reviewed, focusing on specificity, mechanism, and metal ion roles. Applications for gene expression inhibition in various models highlight its potential, with emphasis on critical development steps.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • RNA Therapeutics

Background:

  • Hammerhead ribozymes are catalytic RNA molecules with self-cleaving activity.
  • Understanding their mechanism and specificity is crucial for therapeutic applications.
  • Recent research has focused on refining ribozyme technology for gene regulation.

Purpose of the Study:

  • To review recent developments in hammerhead ribozyme research.
  • To discuss the specificity, mechanism, and metal ion involvement in ribozyme-mediated cleavage.
  • To present applications of hammerhead ribozymes for gene expression inhibition.

Main Methods:

  • Review of recent scientific literature on hammerhead ribozymes.
  • Analysis of studies investigating ribozyme specificity and catalytic mechanisms.

Related Experiment Videos

  • Examination of experimental data from gene inhibition studies in cell culture, animal, and plant models.
  • Main Results:

    • New insights into hammerhead ribozyme specificity and cleavage mechanisms have emerged.
    • The role of metal ions in the catalytic activity of hammerhead ribozymes is further elucidated.
    • Successful applications of hammerhead ribozyme technology for gene silencing across diverse biological systems were demonstrated.

    Conclusions:

    • Hammerhead ribozyme technology shows significant promise for gene expression regulation.
    • Optimization of RNA site selection, delivery, vector development, and cassette construction are key for effective application.
    • Further research will continue to refine ribozyme-based therapeutic strategies.